Respiratory syncytial virus-neutralizing serum antibody titers in infants following palivizumab prophylaxis with an abbreviated dosing regimen

BACKGROUND: Monthly injections of palivizumab during the respiratory syncytial virus (RSV) season in at-risk infants reduces RSV-associated hospitalizations. However, the additive effect of naturally acquired immunity remains unclear. The objective of this study was to assess total neutralizing seru...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Claydon, Jennifer, Sur, Amitava, Callejas, Allison, Ladd, Mihoko, Kwan, Eddie, Taylor, Richard, Turvey, Stuart E., Solimano, Alfonso, Lavoie, Pascal M., Marr, Nico
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2017
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5402955/
https://ncbi.nlm.nih.gov/pubmed/28437470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0176152
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires